Live Updates: COVID-19 Cases
  • World 20,237,888
    World
    Confirmed: 20,237,888
    Active: 6,399,785
    Recovered: 13,100,237
    Death: 737,866
  • USA 5,250,766
    USA
    Confirmed: 5,250,766
    Active: 2,368,844
    Recovered: 2,715,759
    Death: 166,163
  • Brazil 3,057,470
    Brazil
    Confirmed: 3,057,470
    Active: 791,801
    Recovered: 2,163,812
    Death: 101,857
  • India 2,267,153
    India
    Confirmed: 2,267,153
    Active: 640,160
    Recovered: 1,581,640
    Death: 45,353
  • Russia 892,654
    Russia
    Confirmed: 892,654
    Active: 180,972
    Recovered: 696,681
    Death: 15,001
  • South Africa 563,598
    South Africa
    Confirmed: 563,598
    Active: 135,777
    Recovered: 417,200
    Death: 10,621
  • Mexico 480,278
    Mexico
    Confirmed: 480,278
    Active: 105,515
    Recovered: 322,465
    Death: 52,298
  • Peru 478,024
    Peru
    Confirmed: 478,024
    Active: 132,932
    Recovered: 324,020
    Death: 21,072
  • Chile 375,044
    Chile
    Confirmed: 375,044
    Active: 17,563
    Recovered: 347,342
    Death: 10,139
  • Spain 370,060
    Spain
    Confirmed: 370,060
    Active: 341,484
    Recovered: ?
    Death: 28,576
  • Iran 328,844
    Iran
    Confirmed: 328,844
    Active: 23,586
    Recovered: 286,642
    Death: 18,616
  • UK 311,641
    UK
    Confirmed: 311,641
    Active: 265,115
    Recovered: ?
    Death: 46,526
  • Saudi Arabia 289,947
    Saudi Arabia
    Confirmed: 289,947
    Active: 33,270
    Recovered: 253,478
    Death: 3,199
  • Pakistan 284,660
    Pakistan
    Confirmed: 284,660
    Active: 17,799
    Recovered: 260,764
    Death: 6,097
  • Bangladesh 260,507
    Bangladesh
    Confirmed: 260,507
    Active: 106,632
    Recovered: 150,437
    Death: 3,438
  • Italy 250,825
    Italy
    Confirmed: 250,825
    Active: 13,368
    Recovered: 202,248
    Death: 35,209
  • Turkey 241,997
    Turkey
    Confirmed: 241,997
    Active: 11,169
    Recovered: 224,970
    Death: 5,858
  • Germany 218,500
    Germany
    Confirmed: 218,500
    Active: 11,335
    Recovered: 197,900
    Death: 9,265
  • France 202,775
    France
    Confirmed: 202,775
    Active: 89,599
    Recovered: 82,836
    Death: 30,340
  • Canada 120,132
    Canada
    Confirmed: 120,132
    Active: 4,790
    Recovered: 106,355
    Death: 8,987
  • China 84,668
    China
    Confirmed: 84,668
    Active: 802
    Recovered: 79,232
    Death: 4,634
  • Netherlands 59,194
    Netherlands
    Confirmed: 59,194
    Active: 53,037
    Recovered: ?
    Death: 6,157
  • Australia 21,407
    Australia
    Confirmed: 21,407
    Active: 9,217
    Recovered: 11,876
    Death: 314
  • S. Korea 14,626
    S. Korea
    Confirmed: 14,626
    Active: 663
    Recovered: 13,658
    Death: 305
  • New Zealand 1,569
    New Zealand
    Confirmed: 1,569
    Active: 21
    Recovered: 1,526
    Death: 22

NVIDIA’s Deep Learning software and GPUs are being used to discover medical treatments

Author at TechGenyz Artificial Intelligence
Virtual Drug Discovery Tools

With the culture and progress of Artificial Intelligence in modern times, unbelievable possibilities are coming up every now and then. Unbelievable for now, but then: once fire itself was the same for humans! The discovering potential of using AI has its latest finding in the field of medical research.

It is now possible to analyze millions of drug elements with the help of neural networks. The process is to simulate each drug molecule to understand how it will react with the target protein molecule.

Deep learning can pace up the molecular docking process without compromising on accuracy.

You don’t actually need to have the molecule in hand. You can screen billions of compounds and they don’t actually have to exist. – David Koes, assistant professor at the University of Pittsburgh

To find the ideal molecular structure for drug treatment, there are few laws of attraction that scientists need to consider. Lesser the affinity means the drug is too weak to pair with the protein and will result in ineffectively.

There is another major requirement that Koes points out. A general molecule may pair with hundreds of proteins instead of one, which means the pair must be specific.

Presently, Koes and his team are using the principle: ‘opposites attract’ in their neural network. The method also ensures testing molecules that don’t exist!

The team has its deep learning model that uses the cuDNN deep learning software developed by NVIDIA. It has already displayed encouraging results, with offering prediction accuracy of 70% as compared to previous models’ 52% of achievement.

Koes has revealed that the procedure needs GPUs to provide expected results, and has compared it with a self-driving car that is constantly processing. A series of NVIDIA GPUs have been used already for this work, and it includes the likes of Tesla V100, Titan V and more.

The software hasn’t been optimized for inference, but the team has already used it in both training and inference phases of the entire research so far.

Koes envisions that researchers will one day be able to use sliders for activating molecular features as required. He adds that realizing that day is farfetched at present, as the main challenge is to make something which is realistic in terms of both physically and chemically.

If we can get it to the accuracy point where people are motivated to synthesize new molecules, that’s a good indicator that we’re useful. – David Koes

Therefore, be it you are a startup or an established medical institution, you can actually go for drug tests to find new and better treatments if you can get your hands on AI. Progression is thusly simplified.

Check out Koes’ research in this recent paper. You can also hear him at GTC talk: Deep Learning for Molecular Docking.

Career

Subscribe